Endologix Appoints Steve Deitsch to Board of Directors
Endologix LLC has announced the appointment of Steve Deitsch to its Board of Directors. Deitsch brings over 25 years of global leadership experience in the medical technology and healthcare sectors, and is currently the CEO of Caristo Diagnostics, a leader in AI technology.
SANTA ROSA, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced the appointment of Steve Deitsch to its Board of Directors. Mr. Deitsch brings more than 25 years of global leadership experience across medtech and the broader healthcare sector. He currently serves as Chief Executive Officer of Caristo Diagnostics, a global leader in AI technology for